Abstract:Background: Drug research and development has entered into the new epoch of innovation formulation, and the drug delivery system has been in the forefront of pharmaceutical innovation. Chitosan, a natural polysaccharide derived from chitin, due to its well-known biocompatibility and biodegradability, it has been widely used in drug delivery, immunostimulation, tissue regeneration, blood coagulation, wound healing, drug delivery and tissue engineering. Chitosan has become a valuable vaccine adjuvant and delivery carrier, which have attracted increasing attention for its applications. In this paper, we reviewed chitosan nanoparticles, which is a promising biomaterial as vaccine adjuvant and delivery carrier, including characteristics, preparation methods and applications, or even its limitations. We also investigated the mucosal immune delivery route for drug loaded chitosan nanoparticles, such as the routes of oral and nasal. Due to the low toxicity, better biodegradability and adhesivity of chitosan nanoparticles, it can be used as the delivery carrier of vaccine antigens and drugs. These promising studies laid a foundation for the applications of chitosan nanoparticles as a delivery carrier in the vaccine or drug. Methods: We undertook a structured research of biodegradable polymeric nanoparticles of chitosan used as a delivery carrier for the mucosal immunity of vaccine. We have searched the bibliographic databases for peer-reviewed research literature. The outstanding characteristics of the screened papers were described respectively, and a systematic content analysis methodology was used to analyse the findings. Results: Sixty-three papers were included in the review, the majority defined leadership and governance approaches that had impacted upon the polymeric nanoparticles as the delivery carrier for the mucosal immunity of vaccine in therapeutic applications and developments. Thirty-five papers outlined the superiority characteristics of chitosan nanoparticles that applied in the field of vaccine. Twenty-eight papers overviewed the application prospects of chitosan derivatives used as drug delivery systerm. These included current advances in research and clinical applications of chitosan derivatives. This review identified the drug delivery systerm of chitosan or its derivatives, and we described the synthesis methods, applications and challenges of chitosan. Conclusion: The findings of this review identified that the chitosan derivatives were used as delivery carrier for vaccines. It also indicates that the chitosan or its derivatives play a vital role in the drug and vaccine delivery systerm. Keywords: Chitosan nanoparticles, delivery carrier, immune adjuvant, mucosal immunity, vaccine.

Chitosan nanoparticles as gene vector for mucosa vaccination: Preparation, characterization and ability to protect plasmid DNA

Chitosan-DNA Microparticles As Mucosal Delivery System：synthesis, Characterization and Release in Vitro

Chitosan Microparticles Intended for Anti-Caries DNA Vaccine Mucosal Delivery: Synthesis, Characterization and Transfection

Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.

Experimental studies on chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration

Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles

Low Molecular Weight Chitosan in DNA Vaccine Delivery Via Mucosa

Design and formulation of trimethylated chitosan-graft-poly(ε-caprolactone) nanoparticles used for gene delivery.

The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine.

Nano-polyplex Based on Oleoyl-Carboxymethy-chitosan (OCMCS) and Hyaluronic Acid for Oral Gene Vaccine Delivery.

Preparation of Chitosan Nanocomposite Gene Vector

Preparation of Low Molecular Weight Chitosan and Its Efficiency Both in Vitro and in Vivo

Preparation of Chitosan Nanoparticles through a Readily Solvent-Exchange Process for Efficient and Enhanced Gene Delivery

O-Carboxymethyl-chitosan/organosilica Hybrid Nanoparticles As Non-Viral Vectors for Gene Delivery

Novel Chitosan Derivative Nanoparticles Enhance the Immunogenicity of a DNA Vaccine Encoding Hepatitis B Virus Core Antigen in Mice

Advances and Potential Applications of Chitosan Nanoparticles As a Delivery Carrier for the Mucosal Immunity of Vaccine.

Preparation and in Vitro Evaluation of Chitosan-Carbon Nanoparticles

[Feasibility of Chitosan As Gene Therapy Vehicle].

Formulation of Chitosan-Zein Nano-in-Microparticles for Oral DNA Delivery

Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles

Water-soluble and low molecular weight chitosan-based plasmid DNA delivery